Nitric Acid

Nitric Acid

SCHEMBL20985017

NNc1c(Cl)cc(Cl)cc1Cl.O=[N+]([O-])O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
TSHR P16473 4/20 0.47
LMNA P02545 3/20 0.40
GAA P10253 2/20 0.40
HTT P42858 1/20 0.40
MAPK1 P28482 2/20 0.38
MAPT P10636 3/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 2/20 0.34
RECQL P46063 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
HPGD P15428 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1997250 0.82 ALDH1A1 (0.45) ALDH1A1TSHRLMNAGAAMAPT
Nitric Acid SCHEMBL20984060 0.81 TSHR (0.44) ALDH1A1TSHRLMNAGAAHTT
Bromide SCHEMBL20984465 0.80 ALDH1A1 (0.43) ALDH1A1TSHRLMNAGAAMAPT
Hydrochloric Acid SCHEMBL2071416 0.80 ALDH1A1 (0.43) ALDH1A1TSHRLMNAGAAMAPT
Nitric Acid SCHEMBL20984334 0.80 HSP90AA1 (0.40) ALDH1A1TSHRLMNAGAAHTT
Nitric Acid SCHEMBL20984327 0.80 TSHR (0.47) ALDH1A1TSHRLMNAMAPK1MAPT
Nitric Acid SCHEMBL20984681 0.79 ALDH1A1 (0.42) ALDH1A1TSHRLMNAGAAHTT
Oxalic Acid SCHEMBL20984402 0.79 MAPT (0.41) ALDH1A1TSHRLMNAGAAMAPK1
Sulfuric Acid SCHEMBL20984561 0.79 CA1 (0.42) ALDH1A1TSHRLMNAGAAMAPT
Phosphoric Acid SCHEMBL20984848 0.79 MAPT (0.41) ALDH1A1TSHRLMNAGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11040938-B2 Continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) 2021-06-22 US claimed
CN-107663161-B Continuous flow synthesis process of phenylhydrazine salt and substituted phenylhydrazine salt 上海惠和化德生物科技有限公司 2020-04-10 CN claimed
US-20190152896-A1 Continuous Flow Process For the Synthesis of Phenylhydrazine Salts and Substituted Phenylhydrazine Salts SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) 2019-05-23 US claimed
US-11040938-B2 Continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) 2021-06-22 US disclosed
CN-107663161-B Continuous flow synthesis process of phenylhydrazine salt and substituted phenylhydrazine salt 上海惠和化德生物科技有限公司 2020-04-10 CN disclosed
US-20190152896-A1 Continuous Flow Process For the Synthesis of Phenylhydrazine Salts and Substituted Phenylhydrazine Salts SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11040938-B2 Continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts HPD, TYR, PDK2 ALDH1A1 379/4885TSHR 3207/4885LMNA 4619/4885
US-20190152896-A1 Continuous Flow Process For the Synthesis of Phenylhydrazine Salts and Substituted Phenylhydrazine Salts HPD, TYR, PDK2 ALDH1A1 379/4885TSHR 3207/4885LMNA 4619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.